Updated:
GordonMD Global Investments
GordonMD Global Investments: physician-led venture manager in Beverly Hills targeting biotech and health-tech from seed to late stage.
GordonMD Global Investments
GordonMD Global Investments operates out of Beverly Hills under the direction of Craig Gordon, who transitioned from practicing medicine to principal investing. The firm does not disclose its founding year or wealth origin, but its mandate centers on healthcare and life sciences — blending a clinician's judgment with early- and growth-stage venture exposure. Gordon's dual identity as an MD and CIO shapes a deal-selection process that weighs clinical-trial design, FDA interaction, and downstream reimbursement alongside traditional venture metrics. The firm deploys across seed, start-up, early-stage, expansion, late-stage, and growth-equity rounds, favoring biopharma assets, medical devices, diagnostics, and digital-health infrastructure. Its strategy spans direct venture investments, co-investments, and buyout or divestiture opportunities. Publicly surfaced positions remain thin, though the firm's stated mandate targets companies navigating Phase I–III trials and commercialization. Geographic focus gravitates toward North American innovation clusters — Cambridge, the Bay Area, and Southern California — with opportunistic exposure in Europe. Team size and total deployment are not publicly reported, and the firm maintains no visible satellite office. Gordon has not disclosed any adjacent philanthropic vehicle, operating company, or co-investor club, though single-operator asset managers of this profile occasionally co-invest alongside established biotech crossover funds. No dated operational event has been verifiably reported in the last 24 months. GordonMD's structural signature is the MD-investor model: very few asset managers can perform primary clinical due diligence in-house, bypassing the external KOL networks that larger syndicates rely on. That physician-capitalist architecture — a single decision-maker fluent in both the science and the cap table — is the firm's edge in sourcing and diligence, though it also concentrates key-person risk entirely in the founder.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Beverly Hills
Corporate office
Beverly Hills, CA, United States
Principals
Craig Gordon
Founder, CEO & Chief Investment Officer
Sector focus
Frequently asked questions
Who runs investment decisions at GordonMD Global Investments?
Craig Gordon, the firm's Founder, CEO, and Chief Investment Officer, makes all investment decisions. A medical doctor by training, he moved from clinical practice into principal investing, giving him direct scientific and regulatory fluency that shapes the firm's healthcare mandate. The organization does not publicly name any additional investment committee members or partners.
What investment stages does GordonMD target?
GordonMD deploys across the full lifecycle of private healthcare companies — seed, start-up, early-stage, expansion, late-stage, and growth equity. The firm also pursues buyout, divestiture, and co-investment opportunities, though its public record suggests an emphasis on venture and growth-stage therapeutics and health-tech platforms.
Which healthcare subsectors does the firm focus on?
The firm's mandate covers biopharma, medical devices, diagnostics, and digital-health infrastructure. It looks for companies navigating clinical trials, regulatory approval, and commercialization. Specific therapeutic areas are not publicly enumerated, but the clinical due-diligence posture favors assets where FDA pathway and reimbursement design are as critical as the underlying science.
Is GordonMD structured as a single-family office or an asset manager?
GordonMD Global Investments is structured as an asset manager. It is not labeled a family office, and no public disclosure ties the firm's capital base to a single family's wealth. The firm solicits external capital and operates with a generalist investment mandate within healthcare.
Does GordonMD co-invest alongside other funds?
The firm's stated strategy includes co-investment and divestiture transactions. However, no specific co-investors or syndicate partners have been publicly named. Single-operator healthcare managers of this profile commonly co-invest alongside established biotech crossover funds, but that remains unconfirmed for GordonMD.
Does the firm have offices outside Beverly Hills?
No. Public records show only the Beverly Hills, California headquarters. The firm's geographic investment focus centers on North American innovation clusters — Cambridge, the Bay Area, and Southern California — with potential opportunistic exposure in Europe.
What is Craig Gordon's professional background before founding the firm?
Craig Gordon is a medical doctor who transitioned from clinical practice to principal investing. His professional biography is not detailed on the firm's website or LinkedIn, but public references consistently describe him as an MD who now operates as a healthcare investor — a background that informs the firm's clinical due-diligence capability and deal-sourcing model.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: